Yoshikawa Tomoki, Misu Masayasu, Kurosu Takeshi, Takamatsu Yuki, Sugimoto Satoko, Shimojima Masayuki, Ebihara Hideki, Saijo Masayuki
Department of Virology 1, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo, 208-0011, Japan.
Heliyon. 2023 Aug 7;9(8):e18983. doi: 10.1016/j.heliyon.2023.e18983. eCollection 2023 Aug.
Manipulating viral genomes is an essential technique in reverse genetics and recombinant vaccine development. A strategy for manipulating large viral genomes involves introducing their entire genome into bacterial artificial chromosomes and employing genetic tools. For sequence manipulation on bacterial artificial chromosomes (bacterial artificial chromosomes recombineering), a well-established method that relies on the strain GS1783, and the template plasmid, pEPKan-S, is often used. This method, known as markerless DNA manipulation, allows for the generation of a recombinant bacterial artificial chromosome that does not retain the selection markers used during recombination. Although this method is highly innovative, there remains room for improvement as the plasmid is currently only available for positive selection. Additionally, differentiating true recombinants from false negatives often proves time-consuming. Consequently, an improved method for bacterial artificial chromosomes recombineering, which utilizes fluorescent proteins, has been developed. This method's core comprises three plasmids containing the I-SceI recognition site, antibiotic resistance genes (ampicillin, kanamycin, and zeocin), and fluorescent genes (YPet, mOrange, and mScarlet). The success or failure of Red recombination can be confirmed via fluorescent signals. To validate this method, the Lassa virus genes were introduced into the bacterial artificial chromosomes, containing the entire genome of the vaccinia virus strain LC16m8. Consequently, the expression of fluorescent protein genes contributed to positive selection, such as blue-white screening and counter-selection during the first and second Red recombination.
操纵病毒基因组是反向遗传学和重组疫苗开发中的一项关键技术。一种操纵大型病毒基因组的策略是将其整个基因组导入细菌人工染色体并运用遗传工具。对于细菌人工染色体上的序列操纵(细菌人工染色体重组工程),一种常用的成熟方法依赖于GS1783菌株和模板质粒pEPKan - S。这种方法被称为无标记DNA操纵,可生成不保留重组过程中使用的选择标记的重组细菌人工染色体。尽管这种方法极具创新性,但仍有改进空间,因为目前该质粒仅可用于阳性选择。此外,区分真正的重组体和假阴性往往很耗时。因此,已开发出一种利用荧光蛋白改进的细菌人工染色体重组工程方法。该方法的核心由三个质粒组成,分别含有I - SceI识别位点、抗生素抗性基因(氨苄青霉素、卡那霉素和博来霉素)以及荧光基因(YPet、mOrange和mScarlet)。通过荧光信号可确认Red重组的成败。为验证该方法,将拉沙病毒基因导入含有痘苗病毒株LC16m8全基因组的细菌人工染色体中。因此,荧光蛋白基因的表达有助于阳性选择,如在第一次和第二次Red重组期间的蓝白斑筛选和反选择。